BofA/Merrill Lynch Downgrades Novartis (NVS) to Underperform
Tweet
Share
E-mailGet Alerts NVS Hot Sheet
Price: $160.31 +3.73%
Rating Summary:
7 Buy, 14 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 9 | New: 24
Rating Summary:
7 Buy, 14 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 9 | New: 24
Join SI Premium – FREE
BofA/Merrill Lynch downgraded Novartis (NYSE: NVS) from Neutral to Underperform.
For an analyst ratings summary and ratings history on Novartis click here. For more ratings news on Novartis click here.
Shares of Novartis closed at $55.72 yesterday.
For an analyst ratings summary and ratings history on Novartis click here. For more ratings news on Novartis click here.
Shares of Novartis closed at $55.72 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BofA Securities Upgrades Moderna (MRNA) to Neutral
- Morgan Stanley Downgrades Diamondback Energy (FANG) to Equalweight
- UBS Downgrades Cellnex Telecom (CLNX:SM) (CLNXF) to Neutral
Create E-mail Alert Related Categories
DowngradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
